The round was led by Pelion Ventures, with participation from Streamlined, Burst Capital and 8‑Bit Capital. Founded by CEO Matt Faustman, Honey Health is focused on automating the complex administrative workflows that weigh on independent practices, large medical groups and smaller health systems. The company’s “AI staff” agents manage tasks like data retrieval, patient-chart documentation, orders/refills, faxing and prior authorizations.
“Our customers are typically in the middle of the market — large independent practices, hospitals and smaller regional systems — and they want to offload more of the back office to our platform,” said Faustman. “We already have five live agents working across multiple workflows, and this funding will help us scale rapidly to realise our vision of handling the entire back office.”
According to Faustman, healthcare organisations have moved beyond the early phase of AI hype. “We’re entering 2026 where the question isn’t simply ‘Can AI do something?’ — it’s ‘Can we operationalise and scale an AI platform that replaces the patch-work of narrow solutions?’” he explained. “Providers are drowning in point solutions; they want a single platform that can tackle big workflows, not a thousand fragments.”
With this new capital, Honey Health will expand its customer base and deepen its operational platform for back-office tasks — positioning itself as the go-to partner for providers seeking to delegate more administrative burden.
